Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.

TSXV:COV - Post by User

Covalon Technologies Ltd > Highlights from Today's Conference Call

<< Previous

Bullboard Posts

Next >>

Comment by BCONTVentureson May 31, 2021 11:27pm

242 Views

Post# 33301255

RE:RE:Highlights from Today's Conference Call

Great points, thanks for this prophetoffacts.

prophetoffacts wrote: COV can sell the coating business. It is likely worth a significant sum could put the business in a strong position.

"This quarter, we engaged in approximately 10 medical coating customer development projects of various sizes with 3 medical product companies and we have a pipeline of new customer development projects. We are extremely excited about the future revenue potential of these new projects as well as the various projects currently underway with the previously announced major contract with one of the world's largest medical device companies." Today's news release

Here's the deal with one of the largest medical device companies and the payments expected:
Covalon Announces Receipt of First Payment Under New License Agreement | 2018-08-20 | Press Releases | Stockhouse